NEW YORK, NY / ACCESSWIRE / January 28, 2016 / Levi & Korsinsky announces it has commenced an investigation of OvaScience, Inc. (NASDAQGM: OVAS) concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors.
The investigation focuses on whether OvaScience made materially false and misleading statements and/or omitted material information by failing to disclose that OvaScience's AUGMENT procedure did not achieve a significant success rate of clinical pregnancies compared to previous rates achieved without the Company's AUGMENT procedure. Investors have suffered damages following the decline of the Company's common stock from an offering price of $50 per share, to a recent close on January 21, 2016 of $8.74 per share. To obtain additional information, go to: http://zlk.9nl.com/ovas or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com
SOURCE: Levi & Korsinsky, LLP
